Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GTX Regimen for Metastatic Pancreatic Cancer
NCT00996333Phase 2Completed
- Sponsor
- Columbia University
- Start
- Jun 2003
- Primary completion
- Oct 2014
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, docetaxel, capecitabine, sponsored by Columbia University. Started Jun 2003; status: completed.
02
Drugs
gemcitabinedocetaxelcapecitabine
Beyond the preview
Go deeper on NCT00996333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00996333.